NIH Technology Transfer Offices
NIH Institute-level Technology Transfer Offices
Each NIH institute is served by an internal technology transfer office that facilitates the formation of research collaborations and the exchange of research materials, information, and data between the institute and external organizations. These offices handle the review, drafting, and negotiation of various types of transactional agreements for the institutes as described below. These offices also evaluate invention disclosures provided by the institute research staff and make determinations regarding the filing of patent applications on the institute’s inventions. For NIDDK, the institute-level technology transfer office is the Office of Technology Transfer and Development (OTTD).
At-a-Glance: NIH Technology Transfer Offices
|
NIH Institute-level Offices |
Central NIH OTT |
| Invention evaluation, patenting decisions |
Patent prosecution management via contract law firms |
|
Agreement negotiation to support institute mission including:
- Material Transfer Agreements (MTA)
- Confidential Disclosure Agreements (CDA)
- Research Collaboration Agreements (RCA)
- Clinical Trial Agreements (CTA)
- Cooperative Research and Development Agreements (CRADA)
|
License agreement negotiation, including:
- Biological Materials License (BML)
- Commercial Evaluation License (CEL)
- Internal Commercial Use License
- Nonexclusive Patent License
- Exclusive Patent License
|
| Technology transfer educational programs |
Marketing of NIH & FDA inventions to commercial sector |
Central NIH Office of Technology Transfer (NIH OTT)
The NIH OTT has primary responsibility for coordinating the development of technology transfer policies and procedures for the NIH and also provides patenting and licensing services to all ofthe NIH institutes. The NIH OTT negotiates all license agreements for the NIH and FDA.
Page last updated: January 03, 2011
